Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings : hospitalized patients vs. patients treated by their family doctors.
This study is a comparison across treatment settings of two previously published trials, namely the Danish University Antidepressant Group (DUAG) study on citalopram vs. clomipramine in hospitalized patients with major depression, and the Nordic citalopram vs. imipramine study of depressed patients treated by their family doctors.
The Hamilton Depression Scale (HAM-D) had the same level of inter-rater reliability and construct validity in the two settings.
Using a HAM-D score of 7 or less as the criterion for full remission, clomipramine was superior to imipramine and citalopram.
Using a reduction of the baseline HAM-D score by 50% or more as a response criterion, there were no differences between the three antidepressants after 5 or 6 weeks of treatment.
Citalopram showed superior tolerability to the tricyclic antidepressants.
Mots-clés Pascal : Etat dépressif, Trouble humeur, Chimiothérapie, Traitement, Etude comparative, Citalopram, Inhibiteur recapture, Sérotonine, Imipramine, Clomipramine, Composé tricyclique, Antidépresseur, Psychotrope, Modalité traitement, Hôpital, Médecin généraliste, Homme, Diagnostic
Mots-clés Pascal anglais : Depression, Mood disorder, Chemotherapy, Treatment, Comparative study, Reuptake inhibitor, Serotonin, Tricyclic compound, Antidepressant agent, Psychotropic, Application method, Hospital, General practitioner, Human, Diagnosis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0364865
Code Inist : 002B02B02. Création : 10/04/1997.